Kailera Therapeutics, Inc.

KLRA Nasdaq Healthcare · Pharmaceutical Preparations Waltham, MA www.kailera.com/
$11.80
Mkt Cap 1.53B

Clinical-stage biotech developing injectable and oral GLP-1 drugs for obesity and chronic weight management.

—
/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
Running full 6-factor analysis…